Sponsors must aggregate information from healthcare providers, clinical trials, and published studies such as foreign and domestic observational research or experience from registries to demonstrate that the device is providing the expected safety and effectiveness results (Kramer et al., 2013; Brief overview of the Draft Amendment of Pharmaceutical Affairs Law (PAL)).
Under the provision of the Japanese PMD ACT, 1 article 68 10, Japanese MAHs are obligated to report AEs of their own accord within either 15 or 30 days, depending on the nature of the event (Fig. 1a) (Brief overview of the Draft Amendment of Pharmaceutical Affairs Law (PAL)).
The PMS in Japan includes systems for reporting foreign and domestic AEs, identifying safety signals emerging from international markets, and re-filing applications 3 7 years after initial market approval (Kramer et al., 2013; Brief overview of the Draft Amendment of Pharmaceutical Affairs Law (PAL)).
As a safety measure, the Japanese PMD ACT requires MAHs to provide the most recent evidence regarding the effectiveness and safety profile in the package inserts of drugs, medical devices, and regenerative products (Brief overview of the Draft Amendment of Pharmaceutical Affairs Law (PAL)).
Instead, there was a brief conceptual overview – and a list.
'FLUSHING 1880-1935' (Arcadia Publishing, 2005), by James Driscoll, a brief historical overview with photos and illustrations; paperback, $19.99.
Section 2 gives a brief literature overview.
Rowley is also featured in this brief video overview.
Related sites A brief SAGE overview SAGE for beginners.
A brief historical overview of the past two decades of soy and isoflavone research.
I could sense that relief and hope resulted from my brief scientific overview.
